Araştırma Makalesi

Investigation of FBXW7, MASP1 and SERP1 mRNA Expression Levels in Patients with Peripheral Artery Disease

Cilt: 11 Sayı: 1 15 Mart 2026
PDF İndir
TR EN

Investigation of FBXW7, MASP1 and SERP1 mRNA Expression Levels in Patients with Peripheral Artery Disease

Öz

Objective: Peripheral Artery Disease (PAD) is the third leading cause of cardiovascular morbidity worldwide. Given their established roles in lipid metabolism, the lectin-complement pathway, and endoplasmic reticulum stress, we aimed to investigate the potential involvement of the FBXW7, MASP1, and SERP1 genes in PAD. This study sought to evaluate whether these genes could serve as non-invasive biomarkers for the diagnosis of PAD, as they have not been previously explored in this patient population. Materials and Methods: A total of 78 individuals with peripheral arterial disease and 76 healthy individuals were included in the study. Total RNA was extracted from blood samples, and the expressions of FBXW7, MASP1, and SERP1 mRNAs were determined using the real-time polymerase chain reaction (rt-PCR). Results: No statistically significant differences were observed in the expression levels of FBXW7, MASP1, and SERP1 genes between PAD patients and healthy subjects (p > 0.05). Conclusion: Although FBXW7, MASP1, and SERP1 proteins are associated with arterial function, they do not appear to play a direct role in the development of peripheral artery disease.

Anahtar Kelimeler

Destekleyen Kurum

Proje, Türkiye Sağlık Bilimleri Üniversitesi, Bilimsel Araştırma Projeleri Birimi tarafından desteklenmiştir (proje no: 2019/035).

Etik Beyan

Çalışma için etik onay, XXX Yüksek Uzmanlık Eğitim ve Araştırma Hastanesi Klinik Araştırma Etik Kurulu'ndan alınmıştır (Tarih: 20.12.2018, karar no: 2018/7/72). Çalışma, Helsinki Bildirgesi'ne uygun olarak yürütülmüştür.

Kaynakça

  1. 1. SHI Y, XU X, LUAN P, et al. miR-124-3p regulates angiogenesis in peripheral arterial disease by targeting STAT3. Mol Med Rep. 2020;22(6):4890-4898.
  2. 2. Criqui MH, Aboyans V. Epidemiology of peripheral artery disease. Circ Res. 2015;116(9):1509-1526.
  3. 3. Stojkovic S, Jurisic M, Kopp CW, et al. Circulating microRNAs identify patients at increased risk of in-stent restenosis after peripheral angioplasty with stent implantation. Atherosclerosis. 2018;269:197-203.
  4. 4. Hiatt WR, Armstrong EJ, Larson CJ, Brass EP. Pathogenesis of the limb manifestations and exercise limitations in peripheral artery disease. Circ Res. 2015;116(9):1527-1539.
  5. 5. Firnhaber JM, Powell CS. Lower extremity peripheral artery disease: Diagnosis and treatment. Am Fam Physician. 2019;99(6):362-369.
  6. 6. Fowkes FGR, Aboyans V, Fowkes FJI, McDermott MM, Sampson UKA, Criqui MH. Peripheral artery disease: Epidemiology and global perspectives. Nat Rev Cardiol. 2017;14(3):156-170.
  7. 7. Bauersachs R, Zeymer U, Brière JB, Marre C, Bowrin K, Huelsebeck M. Burden of coronary artery disease and peripheral artery disease: A literature review. Cardiovasc Ther. 2019;2019:8295054. doi:10.1155/2019/8295054
  8. 8. Bengoechea-Alonso MT, Ericsson J. The phosphorylation-dependent regulation of nuclear SREBP1 during mitosis links lipid metabolism and cell growth. Cell Cycle. 2016;15(20):2753-2765.

Ayrıntılar

Birincil Dil

İngilizce

Konular

Kalp ve Damar Cerrahisi

Bölüm

Araştırma Makalesi

Yayımlanma Tarihi

15 Mart 2026

Gönderilme Tarihi

30 Ekim 2025

Kabul Tarihi

9 Şubat 2026

Yayımlandığı Sayı

Yıl 2026 Cilt: 11 Sayı: 1

Kaynak Göster

APA
Erdoğan, B., Kuraş, S., Yıılmaz, F., Hacımustafaoğlu, F., Pençe, M. E., & Pence, H. H. (2026). Investigation of FBXW7, MASP1 and SERP1 mRNA Expression Levels in Patients with Peripheral Artery Disease. Online Turkish Journal of Health Sciences, 11(1), 16-23. https://doi.org/10.26453/otjhs.1812461
AMA
1.Erdoğan B, Kuraş S, Yıılmaz F, Hacımustafaoğlu F, Pençe ME, Pence HH. Investigation of FBXW7, MASP1 and SERP1 mRNA Expression Levels in Patients with Peripheral Artery Disease. OTSBD. 2026;11(1):16-23. doi:10.26453/otjhs.1812461
Chicago
Erdoğan, Bekir, Sibel Kuraş, Fatih Yıılmaz, Fatih Hacımustafaoğlu, Mahmud Esad Pençe, ve Halime Hanim Pence. 2026. “Investigation of FBXW7, MASP1 and SERP1 mRNA Expression Levels in Patients with Peripheral Artery Disease”. Online Turkish Journal of Health Sciences 11 (1): 16-23. https://doi.org/10.26453/otjhs.1812461.
EndNote
Erdoğan B, Kuraş S, Yıılmaz F, Hacımustafaoğlu F, Pençe ME, Pence HH (01 Mart 2026) Investigation of FBXW7, MASP1 and SERP1 mRNA Expression Levels in Patients with Peripheral Artery Disease. Online Turkish Journal of Health Sciences 11 1 16–23.
IEEE
[1]B. Erdoğan, S. Kuraş, F. Yıılmaz, F. Hacımustafaoğlu, M. E. Pençe, ve H. H. Pence, “Investigation of FBXW7, MASP1 and SERP1 mRNA Expression Levels in Patients with Peripheral Artery Disease”, OTSBD, c. 11, sy 1, ss. 16–23, Mar. 2026, doi: 10.26453/otjhs.1812461.
ISNAD
Erdoğan, Bekir - Kuraş, Sibel - Yıılmaz, Fatih - Hacımustafaoğlu, Fatih - Pençe, Mahmud Esad - Pence, Halime Hanim. “Investigation of FBXW7, MASP1 and SERP1 mRNA Expression Levels in Patients with Peripheral Artery Disease”. Online Turkish Journal of Health Sciences 11/1 (01 Mart 2026): 16-23. https://doi.org/10.26453/otjhs.1812461.
JAMA
1.Erdoğan B, Kuraş S, Yıılmaz F, Hacımustafaoğlu F, Pençe ME, Pence HH. Investigation of FBXW7, MASP1 and SERP1 mRNA Expression Levels in Patients with Peripheral Artery Disease. OTSBD. 2026;11:16–23.
MLA
Erdoğan, Bekir, vd. “Investigation of FBXW7, MASP1 and SERP1 mRNA Expression Levels in Patients with Peripheral Artery Disease”. Online Turkish Journal of Health Sciences, c. 11, sy 1, Mart 2026, ss. 16-23, doi:10.26453/otjhs.1812461.
Vancouver
1.Bekir Erdoğan, Sibel Kuraş, Fatih Yıılmaz, Fatih Hacımustafaoğlu, Mahmud Esad Pençe, Halime Hanim Pence. Investigation of FBXW7, MASP1 and SERP1 mRNA Expression Levels in Patients with Peripheral Artery Disease. OTSBD. 01 Mart 2026;11(1):16-23. doi:10.26453/otjhs.1812461

Creative Commons Lisansı
 

Online Türk Sağlık Bilimleri Dergisi Creative Commons Atıf-GayriTicari 4.0 Uluslararası Lisansı ile lisanslanmıştır.

Bu, Creative Commons Atıf Lisansı (CC BY-NC 4.0) şartları altında dağıtılan açık erişimli bir dergidir. Orijinal yazar(lar) veya derginin adı ve bu dergideki orijinal yayının kabul görmüş akademik uygulamaya uygun olarak atıfta bulunulması koşuluyla, diğer forumlarda kullanılması, dağıtılması veya çoğaltılmasına izin verilir. Bu şartlara uymayan hiçbir kullanım, dağıtım veya çoğaltmaya izin verilmez.

Makale gönderme süreçleri ve "Telif Hakkı Devir Formu" hakkında yardım almak için tıklayınız.